Image credit: AP Photo/Kathy Young

GW Pharmaceuticals Gets Approval to Market Cannabis Drug for Epilepsy Across Europe

This is the first time the European Medicines Agency has approved a cannabis plant-based CBD medicine.

Business
New York

Leading New York Lawmaker “Optimistic” About Cannabis Legalization’s Chances in 2020

New York Senator Liz Krueger, speaking at a cannabis event on Tuesday evening, also shared where the state’s legalization effort this year went wrong.

Newsletter

More FDA and FTC warnings to CBD sellers • Horizons ETFs: cannabis has lost its “buzz” • & more…

An excerpt from the October 23 edition of the Cannabis Wire Daily newsletter.

Lobbying

The Incredibly Large Lobbying Footprint of Greenwich Biosciences

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states.